Selection and characterization of T-cell variants lacking molecules involved in T-cell activation (T3 T-cell receptor, T44, and T11): analysis of the functional relationship among different pathways of activation.
about
The OX-44 molecule couples to signaling pathways and is associated with CD2 on rat T lymphocytes and a natural killer cell lineMonoclonal antibodies specific for murine CD2 reveal its presence on B as well as T cells.Interdependence of CD3-Ti and CD2 activation pathways in human T lymphocytes.Relative over-reactivity of human versus chimpanzee lymphocytes: implications for the human diseases associated with immune activation.Interaction of nuclear protein p140 with human immunodeficiency virus type 1 TAR RNA in mitogen-activated primary human T lymphocytes.Extrathymic differentiation of T lymphocytes and natural killer cells from human embryonic liver precursorsSpontaneous loss and alteration of antigen receptor expression in mature CD4+ T cells.Two subsets of human T lymphocytes expressing gamma/delta antigen receptor are identifiable by monoclonal antibodies directed to two distinct molecular forms of the receptor.Synergistic T cell activation via the physiological ligands for CD2 and the T cell receptor.New glucocorticoids. Mechanisms of immunological activity at the cellular level and in the clinical setting.Mitogen-induced genes are subject to multiple pathways of regulation in the initial stages of T-cell activation.Phytohemagglutinin-induced activity of cyclic AMP (cAMP) response elements from cytomegalovirus is reduced by cyclosporine and synergistically enhanced by cAMPDefective signal transduction by the CD2 molecule in immature T-cell receptor/CD3- thymocytesHuman CD8+ T lymphocyte subsets that express HLA class I-specific inhibitory receptors represent oligoclonally or monoclonally expanded cell populations.Non-antigen-specific triggering signals for human cytotoxic T lymphocytes.KIR3DS1-Mediated Recognition of HLA-*B51: Modulation of KIR3DS1 Responsiveness by Self HLA-B Allotypes and Effect on NK Cell Licensing.Human T cells recovered from human/Balb radiation chimeras are hypersensitive to human immunodeficiency virus type 1 infection.Human Articular Chondrocytes Regulate Immune Response by Affecting Directly T Cell Proliferation and Indirectly Inhibiting Monocyte Differentiation to Professional Antigen-Presenting Cells.Signal transduction by the CD2 antigen in T cells and natural killer cells: requirement for expression of a functional T cell receptor or binding of antibody Fc to the Fc receptor, Fc gamma RIIIA (CD16).In vitro expansion of CD3/TCR- human thymocyte populations that selectively lack CD3 delta gene expression: a phenotypic and functional analysis.Characterization of CD3+, CD4-, CD8- clones expressing the putative T cell receptor gamma gene product. Analysis of the activation pathways leading to interleukin 2 production and triggering of the lytic machinery.Identification of CD2-/CD3+ T cells in fetal human tissue.A novel 120-kD surface antigen expressed by a subset of human lymphocytes. Evidence that lymphokine-activated killer cells express this molecule and use it in their effector function.Human cytolytic cell clones lacking surface expression of T cell receptor alpha/beta or gamma/delta. Evidence that surface structures other than CD3 or CD2 molecules are required for signal transduction.Genetic models in applied physiology: selected contribution: effects of spaceflight on immunity in the C57BL/6 mouse. II. Activation, cytokines, erythrocytes, and platelets.
P2860
Q24675487-A743E8A4-FEE0-4A15-AD4E-A3C3A717F1D7Q33832516-CFAD5DBF-EF62-466F-90F1-7B0888228DE8Q34048309-BEF67E07-F7C2-46BA-A3BB-B7742687FA67Q34903504-7220D0AB-F7B6-4731-B969-F0405BEDA920Q35845299-A1E0545D-4119-4BA4-AF4D-EDBBA3520291Q36300377-C76ECB00-D974-4767-9FF0-122FDB098112Q36351344-CA5B215A-2E9B-4494-92B3-FA7B2D533929Q36355245-2C367803-1825-4221-AB4E-5DE8DD0A4172Q36355375-F790801E-3DA6-466C-90B7-BCAE8C589B4BQ36587795-FB7286BF-4625-4C60-9E3C-6D7FCEAAE2D1Q36767558-19960EB3-E71B-4AA1-80BF-CD7C3E28709AQ36806198-081C666F-5FAF-4CF3-8ED1-8FA9015CF7A1Q37207106-EDCFD707-046B-4F4D-A688-1C303C459F90Q37240335-537FFCE1-3BDF-4EF6-836F-BC463B355EBBQ38263240-CA339E0A-4678-4D62-A867-712A2C6993B0Q38731024-1A83CE9E-E36B-47D1-8BD7-690941D5633EQ39879908-97014533-7E45-4E56-9427-6A38F150B21DQ41542925-2F70D722-C076-4788-B4AE-649646748A4BQ41655431-56463027-8DBB-45C4-BC3C-6BE186E4CCA0Q41762884-5B0D8163-1E75-4B68-9C34-4D14191A275DQ41898678-24A89D63-5556-45D8-AEC5-BF94385EAD72Q41903284-9872322A-B5BA-4D60-B1F5-D0D2A3DCB205Q41949584-2B1D8120-C261-4A65-85A9-140324B5F93EQ42139007-59A8C09C-985B-48C1-A9EF-CF41C3828A54Q46225632-9651C6DD-3F40-45C2-96A3-28600B41FE19
P2860
Selection and characterization of T-cell variants lacking molecules involved in T-cell activation (T3 T-cell receptor, T44, and T11): analysis of the functional relationship among different pathways of activation.
description
1987 nî lūn-bûn
@nan
1987 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1987 թվականի մարտին հրատարակված գիտական հոդված
@hy
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
name
Selection and characterization ...... ferent pathways of activation.
@ast
Selection and characterization ...... ferent pathways of activation.
@en
Selection and characterization ...... ferent pathways of activation.
@nl
type
label
Selection and characterization ...... ferent pathways of activation.
@ast
Selection and characterization ...... ferent pathways of activation.
@en
Selection and characterization ...... ferent pathways of activation.
@nl
prefLabel
Selection and characterization ...... ferent pathways of activation.
@ast
Selection and characterization ...... ferent pathways of activation.
@en
Selection and characterization ...... ferent pathways of activation.
@nl
P2093
P2860
P356
P1476
Selection and characterization ...... fferent pathways of activation
@en
P2093
P2860
P304
P356
10.1073/PNAS.84.6.1654
P407
P577
1987-03-01T00:00:00Z